Carbon‐Monoxide‐Releasing Molecules for the Delivery of Therapeutic CO In Vivo

The development of carbon‐monoxide‐releasing molecules (CORMs) as pharmaceutical agents represents an attractive and safer alternative to administration of gaseous CO. Most CORMs developed to date are transition‐metal carbonyl complexes. Although such CORMs have showed promising results in the treatment of a number of animal models of disease, they still lack the necessary attributes for clinical development. Described in this Minireview are the methods used for CORM selection, to date, and how new insights into the reactivity of metal‐carbonyl complexes in vivo, together with advances in methods for live‐cell CO detection, are driving the design and synthesis of new CORMs, CORMs that will enable controlled CO release in vivo in a spatial and temporal manner without affecting oxygen transport by hemoglobin.     

Manganese carbonyls bearing tripodal polypyridine ligands as photoactive carbon monoxide-releasing molecules

The recently discovered cytoprotective action of CO has raised interest in exogenous CO-releasing materials (CORMs) such as metal carbonyls (CO complexes of transition metals). To achieve control on CO delivery with metal carbonyls, we synthesized and characterized three Mn(I) carbonyls, namely, [Mn(tpa)(CO)(3)]ClO(4) [1, where tpa = tris(2-pyridyl)amine], [Mn(dpa)(CO)(3)]Br [2, where dpa = N,N-bis(2-pyridylmethyl)amine], and [Mn(pqa)(CO)(3)]ClO(4) [3, where pqa = (2-pyridylmethyl)(2-quinolylmethyl)amine], by crystallography and various spectroscopic techniques. All three carbonyls are sensitive to light and release CO when illuminated with low-power UV (5-10 mW) and visible (λ > 350 nm, ~100 mW) light. The sensitivity of 1-3 to light has been assessed with respect to the number of pyridine groups in their ligand frames. When a pyridine ring is replaced with quinoline, extended conjugation in the ligand frame increases the absorptivity and makes the resulting carbonyl 3 more sensitive to visible light. These photosensitive CORMs (photoCORMs) have been employed to deliver CO to myoglobin under the control of light. The superior stability of 3 in aqueous media makes it a photoCORM suitable for inducing vasorelaxation in mouse aortic muscle rings.     

Light-assisted and remote delivery of carbon monoxide to malignant cells and tissues: Photochemotherapy in the spotlight

The recent discovery of the salutary effects of carbon monoxide (CO) in chronic obstructive pulmonary disease (COPD), ischemic perfusion damage, graft implantation, as well as its pro-apoptotic effects on hyper-proliferating cells has raised interest in delivering small doses of CO to biological targets under controlled conditions. In such attempts, photoactive metal carbonyl complexes (photoCORMs) have shown promise and several accounts of cancer cell eradication with light-triggered CO release from photoCORMs have been reported. CO releasing molecules (CORMs) and photoCORMs have been incorporated within biocompatible drug delivery vehicles such as carboxymethyl chitosan or mesoporous silica-based nanoparticles and the composite materials (photoCORs) have been successfully employed in controlled CO delivery to cancer cells to cause rapid CO-induced apoptosis. Fiber optic technology has also been utilized for remote delivery of CO to not easily accessible targets. Reports on all these therapeutic modalities for on-demand CO delivery to malignant targets in a highly localized fashion have opened up the possibility of phototherapy of cancer with the use of an unusual so-called “toxic” molecule. This review highlights the methodologies used in CO photochemotherapy reported so far along with analysis of their therapeutic outcomes, and possible improvements for better applicability.     

Designed iron carbonyls as carbon monoxide (CO) releasing molecules: rapid CO release and delivery to myoglobin in aqueous buffer, and vasorelaxation of mouse aorta

The physiological roles of CO in neurotransmission, vasorelaxation, and cytoprotective activities have raised interest in the design and syntheses of CO-releasing materials (CORMs) that could be employed to modulate such biological pathways. Three iron-based CORMs, namely, [(PaPy(3))Fe(CO)](ClO(4)) (1), [(SBPy(3))Fe(CO)](BF(4))(2) (2), and [(Tpmen)Fe(CO)](ClO(4))(2) (3), derived from designed polypyridyl ligands have been synthesized and characterized by spectroscopy and X-ray crystallography. In these three Fe(II) carbonyls, the CO is trans to a carboxamido-N (in 1), an imine-N (in 2), and a tertiary amine-N (in 3), respectively. This structural feature has been correlated to the strength of the Fe-CO bond. The CO-releasing properties of all three carbonyls have been studied in various solvents under different experimental conditions. Rapid release of CO is observed with 2 and 3 upon dissolution in both aqueous and nonaqueous media in the presence and absence of dioxygen. With 1, CO release is observed only under aerobic conditions, and the final product is an oxo-bridged diiron species while with 2 and 3, the solvent bound [(L)Fe(CO)](2+) (where L = SBPy(3) or Tpmen) results upon loss of CO under both aerobic and anaerobic conditions. The apparent rates of CO loss by these CORMs are comparable to other CORMs such as [Ru(glycine)(CO)(3)Cl] reported recently. Facile delivery of CO to reduced myoglobin has been observed with both 2 and 3. In tissue bath experiments, 2 and 3 exhibit rapid vasorelaxation of mouse aorta muscle rings. Although the relaxation effect is not inhibited by the soluble guanylate cyclase inhibitor ODQ, significant inhibition is observed with the BK(Ca) channel blocker iberiotoxin.     

Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes

The advent of CO as a small molecule that, in addition to NO, elicits essential biological functions has initiated the search for compounds and complexes capable of releasing CO in a well defined manner under physiological conditions. Since some pharmacological and therapeutic effects of CO have been established in preclinical studies, tailor-made CO-releasing molecules (CORMs) which could be utilized as pharmaceuticals could be of great benefit for many patients. Release of CO(2) is one of the most common features in chemistry and NO producing molecules are very well established but compounds with CO-releasing properties are rare. Some of the more promising candidates and molecules under study are discussed in this article. Furthermore, molecules that possess intrinsic features to serve as potential CO-RMs and merit in depth investigations are proposed. The focus is thereby on main group compounds and on transition element complexes. It should be emphasized that CORMs not only have encouraging prospects as therapeutic agents but may also be significant for synthetic pathways to novel complexes containing the CO ligand. To underline the prospects of CORMs, the chemical part is embedded in a biological and medicinal context.     

Tetrachlorocarbonyliridates: water-soluble carbon monoxide releasing molecules rate-modulated by the sixth ligand

A new family of compounds is presented as potential carbon monoxide releasing molecules (CORMs). These compounds, based on tetrachlorocarbonyliridate(III) derivatives, were synthesized and fully characterized by X-ray diffraction, electrospray mass spectrometry, IR, NMR, and density functional theory calculations. The rate of CO release was studied via the myoglobin assay. The results showed that the rate depends on the nature of the sixth ligand, trans to CO, and that a significant modulation on the release rate can be produced by changing the ligand. The reported compounds are soluble in aqueous media, and the rates of CO release are comparable with those for known CORMs, releasing CO at a rate of 0.03-0.58 μM min(-1) in a 10 μM solution of myoglobin and 10 μM of the complexes.     

Anticancer activities of manganese-based photoactivatable CO-releasing complexes (PhotoCORMs) with benzimidazole derivative ligands

Carbon monoxide is an important signaling molecule which is produced by heme oxygenase-1. CO shows antiproliferative activity against cancer cells; hence, activation of HO-1 is a significant inhibition strategy against tumor formation and survival of cancer cells. In this work, manganese-based CO-releasing molecules (CORMs) were designed and synthesized to inhibit breast cancer cell proliferation. Human invasive ductal breast cancer cells (MCF-7) were treated with the synthesized CORMs to investigate the effect of the complexes on breast cancer survival under UV light. In vitro experiments indicated that the complexes inhibited breast cancer cell proliferation, and further, the antiproliferative effects were increased under UV light. Thus, these novel CORMs may provide a drug template for the treatment of invasive ductal breast cancer.     

基于席夫碱配体的锰羰基配合物可见光诱导释放一氧化碳性能

利用五羰基溴化锰和2-吡啶甲醛以及卤代苯胺通过一步法合成得到了3个含席夫碱配体的锰羰基配合物[Mn(CO)₃(py(CH=N)ph-X)Br],其中X=Cl (1)、Br (2)、I (3),并采用核磁、X射线单晶衍射、红外光谱、紫外可见光谱和荧光光谱对其进行了表征。这类配合物在非光照下稳定,在可见光(LED蓝光、绿光和红光)作用下分解释放CO,可以作为光诱导的一氧化碳释放剂(photoCORMs)。研究表明蓝光是促进配合物分解释放CO的最有效光源。此外,CO释放动力学分析显示配合物分解释放CO过程符合一级动力学模型。配合物3的释放研究表明脱氧肌红蛋白能够捕捉所释放的CO。尽管这些配合物本身的细胞毒性(IC50)达到微摩尔级,但光照下的细胞兼容性有显著改善,上升为接近100微摩尔级。这些配合物具有荧光性质,在450 nm激发波长下在500～700 nm范围内发射一定强度的荧光,可以作为荧光标记物用以监测细胞或生物体内释放剂分布及CO释放情况。     

基于席夫碱配体的锰羰基配合物可见光诱导释放一氧化碳性能

利用五羰基溴化锰和2-吡啶甲醛以及卤代苯胺通过一步法合成得到了3个含席夫碱配体的锰羰基配合物[Mn (CO)₃(py (CH=N) ph-X) Br],其中X=Cl (1)、Br (2)、I (3),并采用核磁、X射线单晶衍射、红外光谱、紫外可见光谱和荧光光谱对其进行了表征。这类配合物在非光照下稳定,在可见光(LED蓝光、绿光和红光)作用下分解释放CO,可以作为光诱导的一氧化碳释放剂(photoCORMs)。研究表明蓝光是促进配合物分解释放CO的最有效光源。此外,CO释放动力学分析显示配合物分解释放CO过程符合一级动力学模型。配合物3的释放研究表明脱氧肌红蛋白能够捕捉所释放的CO。尽管这些配合物本身的细胞毒性(IC₅₀)达到微摩尔级,但光照下的细胞兼容性有显著改善,上升为接近100微摩尔级。这些配合物具有荧光性质,在450 nm激发波长下在500~700 nm范围内发射一定强度的荧光,可以作为荧光标记物用以监测细胞或生物体内释放剂分布及CO释放情况。     

Carbon monoxide-releasing micelles for immunotherapy

With the discovery of important biological roles of carbon monoxide (CO), the use of this gas as a therapeutic agent has attracted attention. However, the medical application of this gas has been hampered by the complexity of the administration method. To overcome this problem, several transition-metal carbonyl complexes, such as Ru(CO)(3)Cl(glycinate), [Ru(CO)(3)Cl(2)](2), and Fe(η(4)-2-pyrone)(CO)(3), have been used as CO-releasing molecules both in vitro and in vivo. We sought to develop micellar forms of metal carbonyl complexes that would display slowed diffusion in tissues and thus better ability to target distal tissue drainage sites. Specifically, we aimed to develop a new CO-delivery system using a polymeric micelle having a Ru(CO)(3)Cl(amino acidate) structure as a CO-releasing segment. The CO-releasing micelles were prepared from triblock copolymers composed of a hydrophilic poly(ethylene glycol) block, a poly(ornithine acrylamide) block bearing Ru(CO)(3)Cl(ornithinate) moieties, and a hydrophobic poly(n-butylacrylamide) block. The polymers formed spherical micelles in the range of 30-40 nm in hydrodynamic diameter. Further characterization revealed the high CO-loading capacity of the micelles. CO-release studies showed that the micelles were stable in physiological buffer and serum and released CO in response to thiol-containing compounds such as cysteine. The CO release of the micelles was slower than that of Ru(CO)(3)Cl(glycinate). In addition, the CO-releasing micelles efficiently attenuated the lipopolysaccharide-induced NF-κB activation of human monocytes, while Ru(CO)(3)Cl(glycinate) did not show any beneficial effects. Moreover, cell viability assays revealed that the micelles significantly reduced the cytotoxicity of the Ru(CO)(3)Cl(amino acidate) moiety. This novel CO-delivery system based on CO-releasing micelles may be useful for therapeutic applications of CO.     

Reactions of silicon atoms and small clusters with CO: experimental and theoretical characterization of SinCO (n=1-5), Si2(CO)2, c-Si2(mu-O)(mu-CSi), and c-Si2(mu-O)(mu-CCO) in solid argon

Reactions of silicon atoms and small clusters with carbon monoxide molecules in solid argon have been studied using matrix isolation infrared absorption spectroscopy. In addition to the previously reported SiCO monocarbonyl, Si(2)(CO)(2) and Si(n)CO (n=2-5) carbonyl molecules were formed spontaneously on annealing and were characterized on the basis of isotopic substitution and theoretical calculations. It was found that Si(2)CO, Si(3)CO, and Si(5)CO are bridge-bonded carbonyl compounds, whereas Si(4)CO is a terminal-bonded carbonyl molecule. The Si(2)(CO)(2) and Si(3)CO molecules photochemically rearranged to the more stable c-Si(2)(mu-O)(mu-CCO) and c-Si(2)(mu-O) (mu-CSi) isomers where Si(2) is inserted into the CO triple bond.     

Reactions of gadolinium atoms and dimers with CO: formation of gadolinium carbonyls and photoconversion to CO activated molecules

Reactions of gadolinium atoms and dimers with carbon monoxide molecules in solid argon have been studied using matrix isolation infrared absorption spectroscopy. Mononuclear Gd(CO)x (x = 1-3) and dinuclear Gd2(CO)x (x = 1, 2) gadolinium carbonyls formed spontaneously on annealing. The Gd(CO)x complexes are CO terminal-bonded carbonyls, whereas the Gd2CO and Gd2(CO)2 carbonyl complexes were characterized to have asymmetrically bridging and side-on-bonded CO, which are drastically activated with remarkably low C-O stretching frequencies. The cyclic Gd2(mu-C)(mu-O) and Gd3(mu-C)(mu-O) molecules in which the C-O triple bond is completely cleaved were also formed on annealing. The Gd2(CO)2 complex rearranged to the more stable c-Gd2(mu-O)(mu-CCO) isomer, which also has a four-membered ring structure with one CO being completely activated.     

Synthesis, characterization, and reactivity of the stable iron carbonyl complex [Fe(CO)(N4Py)](ClO4)2: photoactivated carbon monoxide release, growth inhibitory activity, and peptide ligation

Photoactivated carbon monoxide (CO) release by the iron carbonyl complex [Fe(II)(CO)(N4Py)](ClO(4))(2) (1) is described. Compound 1 is a low-spin ferrous complex that is highly stable and soluble in aerobic aqueous solutions. CO release was studied by the substitution of MeCN for CO, which displays saturation kinetics, and by the transfer of CO to deoxymyoglobin, which is slow in the dark but fast upon irradiation with UV light (365 nm). Compound 1 is active against PC-3 prostate cancer cells and shows potent photoinduced cytotoxicity. In addition, the iron carbonyl complex was attached to a short peptide toward the goal of tissue or cell-specific delivery.     

Binding and photodissociation of CO in iron(II) complexes for application in positron emission tomography (PET) radiolabelling

(R-DAB)FeI(2) complexes containing bidentate diimide ligands (R-DAB = RN=CH-CH=NR; R = (i)Pr, c-C(6)H(11)) have been investigated for their ability to react with carbon monoxide to form iron(II) dicarbonyl complexes, (R-DAB)FeI(2)(CO)(2). Solution IR spectroscopy revealed two νCO stretches between 2000 and 2040 cm(-1) corresponding to a cis-arrangement of the carbonyl ligands around the iron. Photochemical decarbonylation was achieved by UV irradiation (365 nm), which occurred within 5 min as evidenced by solution IR spectroscopy. (c-C(6)H(11)-DAB)FeI(2) has been characterised by X-ray crystallography. Reactions using (11)C-labelled carbon monoxide were investigated and revealed that both (R-DAB)FeI(2) species were not effective as trapping complexes due to the low concentrations of [(11)C]CO used in these experiments. A Fe(TPP)(THF)(x) (TPP = tetraphenylporphyrin) complex was investigated with unlabelled CO and the monocarbonyl adduct Fe(TPP)(THF)CO was formed in situ as identified by IR spectroscopy (νCO = 1966 cm(-1)) yet was stable to CO loss upon UV irradiation. Carbonylation reactions of in situ-generated Fe(TPP)(THF)(x) using [(11)C]CO revealed that 97% of the [(11)C]CO stream could be trapped in one pass of the gas at room temperature and at atmospheric pressure.     

Synthesis and structures of photoactive rhenium carbonyl complexes derived from 2‐(pyridin‐2‐yl)‐1,3‐benzothiazole, 2‐(quinolin‐2‐yl)‐1,3‐benzothiazole and 1,10‐phenanthroline

Carbon monoxide (CO) has recently been identified as a gaseous signaling molecule that exerts various salutary effects in mammalian pathophysiology. Photoactive metal carbonyl complexes (photoCORMs) are ideal exogenous candidates for more controllable and site‐specific CO delivery compared to gaseous CO. Along this line, our group has been engaged for the past few years in developing group‐7‐based photoCORMs towards the efficient eradication of various malignant cells. Moreover, several such complexes can be tracked within cancerous cells by virtue of their luminescence. The inherent luminecscent nature of some photoCORMs and the change in emission wavelength upon CO release also provide a covenient means to track the entry of the prodrug and, in some cases, both the entry and CO release from the prodrug. In continuation of the research circumscribing the development of trackable photoCORMs and also to graft such molecules covalently to conventional delivery vehicles, we report herein the synthesis and structures of three rhenium carbonyl complexes, namely, fac‐tricarbonyl[2‐(pyridin‐2‐yl)‐1,3‐benzothiazole‐κ²N ,N ′](4‐vinylpyridine‐κN )rhenium(I) trifluoromethanesulfonate, [Re(C₇H₇N)(C₁₂H₈N₂S)(CO)₃](CF₃SO₃), ( 1 ), fac‐tricarbonyl[2‐(quinolin‐2‐yl)‐1,3‐benzothiazole‐κ²N ,N ′](4‐vinylpyridine‐κN )rhenium(I) trifluoromethanesulfonate, [Re(C₇H₇N)(C₁₆H₁₀N₂S)(CO)₃](CF₃SO₃), ( 2 ), and fac‐tricarbonyl[1,10‐phenanthroline‐κ²N ,N ′](4‐vinylpyridine‐κN )rhenium(I) trifluoromethanesulfonate, [Re(C₇H₇N)(C₁₂H₈N₂)(CO)₃](CF₃SO₃), ( 3 ). In all three complexes, the Re^I center resides in a distorted octahedral coordination environment. These complexes exhibit CO release upon exposure to low‐power UV light. The apparent CO release rates of the complexes have been measured to assess their comparative CO‐donating capacity. The three complexes are highly luminescent and this in turn provides a convenient way to track the entry of the prodrug molecules within biological targets.     

CO-releasing properties and anticancer activities of manganese complexes with imidazole/benzimidazole ligands

Carbon monoxide (CO) is an important signaling molecule which plays significant roles in the pathogenesis of cancer. CO is produced by enzymatic degradation of heme in mammals. Heme oxygenase 1 (HO-1) catalyzes the breakdown of heme into CO, ferrous iron, and biliverdin. CO induces HO-1 and inhibits cell proliferation. Cancer cells exposed to several stress factors (hypoxia, reactive oxygen species, cis-platin, and oxidative stress), and HO-1 displays cytoprotective role against oxidative stress and inhibits apoptosis, metastases, angiogenesis, and cell proliferation processes. Therefore, metal containing CO-releasing molecules (CORMs) have been designed as an effective cancer treatment strategy. CORMs are responsible for releasing controlled amounts of CO to cells and tissues. Thus, we synthesized [Mn(CO)₃(bpy)L]X manganese containing CORMs [bpy = 2,2′-bipyridine, X = hexafluorophosphate (PF₆), trifluoromethanesulfonate (OTf), L = imidazole, methylimidazole, benzimidazole, N-benzylbenzimidazole, N-(4-chlorobenzyl)benzimidazole] to release CO in human invasive ductal breast (MCF-7) cell line. In vitro experiments indicated that the compounds inhibited cell proliferation and exhibited cytotoxic effect on breast cancer cells. Moreover, side groups of the compounds enhanced the anticancer effects in MCF-7 cell line. These manganese containing CORMs gave promising results and may be used as a drug template for effective treatment of invasive ductal breast carcinoma.     

Carbon dioxide coordination and activation by niobium oxide molecules

Carbon dioxide coordination and activation by niobium oxide molecules were studied by matrix isolation infrared spectroscopy. It was found that the niobium monoxide molecule reacted with carbon dioxide to form the niobium dioxide carbonyl complex NbO(2)(η(1)-CO) spontaneously on annealing in solid neon. The observation of the spontaneous reaction is consistent with theoretical predictions that this carbon dioxide activation process is both thermodynamically exothermic and kinetically facile. In contrast, four niobium dioxide-carbon dioxide complexes exhibiting three different coordination modes of CO(2) were formed from the reactions between niobium dioxide and carbon dioxide, which proceeded with the initial formation of the η(1)-O bound NbO(2)(η(1)-OCO) and NbO(2)(η(1)-OCO)(2) complexes on annealing. The NbO(2)(η(1)-OCO) complex rearranged to the η(2)-O,O bound NbO(2)(η(2)-O(2)C) isomer under visible light irradiation, while the NbO(2)(η(1)-OCO)(2) complex isomerized to the NbO(2)(η(1)-OCO)(η(2)-OC)O structure involving an η(2)-C,O ligand under IR excitation. In these niobium dioxide carbon dioxide complexes, the η(1)-O coordinated CO(2) ligand serves as an electron donor, whereas both the η(2)-C,O and η(2)-O,O coordinated CO(2) ligands act as electron acceptors.     

The infrared spectra and theoretical calculations of frequencies of fac-tricarbonyl octahedral complexes of manganese(I)

The carbonyl stretching frequencies in the infrared spectra of 38 fac-tricarbonyl octahedral complexes of manganese(I) prepared in this laboratory were determined. These complexes may be grouped into three types: (a) neutral complexes of the structure (CO)(3)Mn(P-P)Z where P-P represents depe, dppe, or dppp, and Z represents various anionic functional groups bonded to the manganese; (b) ionic complexes of the structure [(CO)(3)Mn(P-P)Z](+)BF(4)(-) where Z represents various neutral molecules possessing one phosphorous, nitrogen, or oxygen atom coordinated to the manganese; (c) complexes of the structure (CO)(3)Mn(pn)Z where the chelating pn represents 1,1-diphenylphosphino-2,2-dimethylaminoethane, Ph(2)PCH(2)CH(2)NMe(2). All of these complexes show three carbonyl stretching modes (2A' + A"). The effects on the frequencies of these modes induced by both the various Z groups and the various ligands are discussed. Theoretical calculations (B3LYP/6-31G) with optimization of the full molecule make it possible to distinguish between the three stretching modes and to make unambiguous assignments of appropriate symmetry species to each.     

Elucidation of the CO‐Release Kinetics of CORM‐A1 by Means of Vibrational Spectroscopy

CO‐releasing molecules (CORMs) are developed for investigations of the interaction between the signaling molecule carbon monoxide (CO) and cells or tissue. Prior to their application these molecules must be fully characterized with respect to their CO‐release mechanism. One widely used CORM for biological application is sodium boranocarbonate (CORM‐A1), which shows pH‐dependent CO liberation. The complete reaction mechanism of CORM‐A1 is not fully understood yet. Therefore, in this contribution time‐resolved gas‐phase IR spectroscopy is used to monitor the headspace above decaying CORM‐A1 solutions at four different pH values (5.8 to 7.4). Borane carbonyl is found as an intermediate in the gas phase, which is formed during CORM degradation and further decays to CO. Concentration profiles of a pseudoconsecutive first‐order reaction are successfully fitted to specific band areas of the measured gas‐phase spectra, and the rate constants are obtained. The production of borane carbonyl is strongly pH dependent (half‐lives between 5 and 106 min), whereas the decay of borane carbonyl in the gas phase is nearly constant with a half‐life of about 33 min. The ratio of liberated CO molecules per CORM‐A1 is determined to be 0.91±0.09, and boric acid is identified as further end product.     

Reactions of carbon monoxide with free palladium oxide clusters: strongly size dependent competition between adsorption and combustion

The gas phase reactions of carbon monoxide with small mass-selected clusters of palladium, Pd(x)(+) (x = 2-7), and their oxides, Pd(x)O(+) (x = 2-7) and Pd(x)O(2)(+) (x = 4-6), have been investigated in a radio frequency ion trap operated under multi-collision conditions. The bare palladium clusters were found to readily adsorb CO yielding a highly size dependent product pattern. Most interestingly, the reactions of the pre-oxidized palladium clusters with CO lead to very similar product distributions of Pd(x)(CO)(z)(+) complexes as in the case of the corresponding pure Pd(x)(+) clusters. Consequently, it has been concluded that the investigated palladium oxide clusters efficiently oxidize CO under formation of the bare clusters, which further adsorb CO molecules yielding the previously observed Pd(x)(CO)(z)(+) product complex distributions. This CO combustion reaction has been observed even at temperatures as low as 100 K. However, for Pd(2)O(+), Pd(6)O(+), Pd(6)O(2)(+), and Pd(7)O(+) a competing reaction channel yielding palladium oxide carbonyls Pd(x)O(CO)(z)(+) could be detected. The latter adsorption reaction may even hamper the CO combustion under certain reaction conditions and indicates enhanced activation barriers involved in the CO oxidation and/or the CO(2) elimination process on these clusters.